Press release
Ascend AI Unveils Scopenotes - The AI Assistant for Client Servicing
AI tool generates actionable outcomes from client conversations in just secondsImage: https://www.abnewswire.com/uploads/0803db4a0aecc74d71d1210515f7c1c1.png
LONDON - April 11, 2024 - Scopenotes is a new AI assistant built to streamline client communication by converting client meetings into valuable outcomes for client service professionals in a few clicks. With Scopenotes, these professionals can access an automated summary of client decisions, feedback, and agreed next steps within seconds of signing out of a meeting.
Professionals who work in client-facing roles regularly face the challenge of managing conversations and tracking interactions in real time. Failure to keep up with scope changes can easily lead to overservicing and related issues that complicate client relationship management [https://www.businessnewsdaily.com/15957-small-business-customer-relationship-management.html] and negatively impact revenue.
This AI assistant from Ascend AI tackles these issues with note-taking capabilities that leverage active listening to capture feedback accurately, understand client needs, and offer customized solutions. With Scopenotes, professionals can cut down on the amount of time they spend on post-meeting admin tasks. For one Scopenotes client [https://www.linkedin.com/pulse/scopenotes-innovating-site-visits-ai-assistance-scopenotes-ai-tyfif/?trackingId=TOF%2FF7hkSJCsBs%2By3btmjw%3D%3D], this translates to a 45-minute time saving as she now spends 15 minutes on tasks that would normally take 1 hour.
"Many client service professionals we've spoken to are weighed down by the responsibility of keeping up with client conversations," says Scopenotes co-founder and AI expert Jeffrey Davis. "We built our AI assistant specifically to help capture requirements, whether during in-person or virtual meetings, and translate them into actionable outcomes. This offers professionals valuable insight into what to prioritize, in addition to giving them the bandwidth they need to focus on tasks that clients value."
For client service professionals, what seems like a simple meeting is followed by lots of administrative tasks. These could include creating client briefs, generating follow-up emails, recording RFP responses, and keeping track of project deliverables. This AI assistant from Ascend AI seamlessly captures, analyzes, and uses information from every conversation, freeing professionals up to focus on delivering value to clients.
Users of Scopenotes can employ this user-friendly AI assistant for different client service tasks. Scopenotes has the ability to record, transcribe, and summarize meetings and discussions. The fact that it can automatically generate a follow-up email for professionals to send to their clients directly from meeting notes simplifies the follow-up process. Scopenotes also offers customizable templates for meeting summaries, decisions, next steps, and client briefs. With streamlined project management and client engagement tools, Scopenotes also takes the hassle out of customer relationship management.
Since Scopenotes is built specifically around the pain points that client service professionals need help with, this tool stands out from other AI assistants. Whereas conventional AI assistants focus on the technology solving the problem, Scopenotes was developed with a human-centric focus on the problem.
With its unique features and capabilities, Scopenotes empowers client service professionals to differentiate themselves from the competition and deliver exceptional value to clients. By summarizing lengthy discussions from both virtual and in-person meetings within seconds, Scopenotes fills a gap in the market and ensures that all client expectations are met. This focus on client expectations empowers professionals in client-facing roles to focus on the aspects of a project that matter most to their clients.
Scopenotes streamlines client service roles [https://scopenotes.ai/about] by generating an actionable list of conversation outcomes to keep client service professionals focused on what clients care about. In this way, Scopenotes is built to help these professionals offer meaningful and unforgettable services to their clients, increasing customer loyalty and retention.
About Scopenotes
Scopenotes is an AI assistant from Ascend AI that generates conversation outcomes for client service professionals, empowering them to focus on what matters to clients. Beyond streamlining the more tedious and repetitive aspects of client relationship management, Scopenotes enables professionals to stand out for delivering meaningful services to their clients.
Media Contact
Company Name: Scopenotes
Contact Person: Chris
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ascend-ai-unveils-scopenotes-the-ai-assistant-for-client-servicing]
State: London
Country: United Kingdom
Website: https://scopenotes.ai
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ascend AI Unveils Scopenotes - The AI Assistant for Client Servicing here
News-ID: 3460813 • Views: …
More Releases from ABNewswire
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies.
The Alzheimer's disease market was valued at approximately USD 3,610 million…
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others.
The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,…
Graves' Disease Market Size in the 7MM was ~USD 4,400 million in 2023 and is exp …
DelveInsight's "Graves' Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Graves' Disease, historical and forecasted epidemiology as well as the Graves' Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Explore Graves' Disease Market Trends, treatment landscapes, and emerging therapies shaping the future. Download sample report @ [https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Graves' Disease Market Report
* In December…
Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9% by 2034, es …
DelveInsight's 'Myelofibrosis Market Insight, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of myelofibrosis, historical and forecasted epidemiology as well as the myelofibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover more about the Myelofibrosis Market in detail @ Myelofibrosis Treatment Market Report @ https://www.delveinsight.com/sample-request/myelofibrosis-mf-market [https://www.delveinsight.com/sample-request/myelofibrosis-mf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myelofibrosis Market Report
* On January 09, 2026, Swedish Orphan…
